posted on 2018-11-11, 12:33authored byNICOLAS ALEJANDRO ALCARAZ
This thesis was undertaken to develop a novel drug carrier for diseases such as cancer which would exhibit better localised and controlled release of contents to improve treatment efficacy and reduce side effects. This involved using lipid-based nanotechnology and bioorthogonal chemistry together in an attempt to specifically target the tumor cells.
History
Campus location
Australia
Principal supervisor
Ben Boyd
Additional supervisor 1
Angus Johnston
Year of Award
2018
Department, School or Centre
Drug Delivery, Disposition and Dynamics
Additional Institution or Organisation
ARC Centre of Excellence in Bio-Nano Science and Technology (CBNS)